Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
RECURSION PHARMACEUTICALS, INC. | Director | Class A Common Stock | 105K | $649K | $6.18 | Nov 20, 2024 | Direct |
RECURSION PHARMACEUTICALS, INC. | Director | Stock Option (Right to Buy) | 82.8K | Nov 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RXRX | RECURSION PHARMACEUTICALS, INC. | Nov 20, 2024 | 8 | $0 | 4 | Nov 22, 2024 | Director |
RXRX | RECURSION PHARMACEUTICALS, INC. | Nov 20, 2024 | 0 | $0 | 3 | Nov 22, 2024 | Director |